Sustento Bibliográfico

 

1. Francisconi RS, Huacho PMM, Tonon CC, Bordini EAF, Correia MF, Sardi JCO, Spolidorio DMP. Antibiofilm efficacy of Tea Tree Oil and of its main component terpinen-4-ol against candida albicans. Brazilian Oral Research. 2020; 34.  

​2. Rahman B, Alkawas S, Al Zubaidi E, Adel OI, Hawas N. Comparative antiplaque and antigingivitis effectiveness of tea tree oil mouthwash and a cetylpyridinium chloride mouthwash: A randomized controlled crossover study. Contemporary Clinical Dentistry. 2014.  

​3. Graziano TS, Calil CM, Sartoratto A, Franco GC, Groppo FC, COGO-MÜLLER K. In vitro effects of Melaleuca alternifolia essential oil on growth and production of volatile sulphur compounds by oral bacteria. Journal of Applied Oral Science. 2016; 24(6):582–.  

4. Miake Y, Saeki Y, Takahashi M, Yanagisawa T. Remineralization effects of xylitol on demineralized enamel. Journal of Electron Microscopy. 2003; 52(5):471–6.  

​5. Rafeek R, Carrington CVF, Gomez A, Harkins D, Torralba M, Kuelbs C, Addae J, Moustafa A, Nelson KE. Xylitol and sorbitol effects on the microbiome of saliva and plaque. J Oral Microbiol. 2018 Oct 23;11(1).  

​6. Wong MCM, Clarkson J, Glenny A-M, Lo ECM, Marinho VCC, Tsang BWK, et al. Cochrane reviews on the benefits/risks of fluoride toothpastes. J Dent Res [Internet]. 2011; 90(5):573–9.  

​7. Levy SM. Review of fluoride exposures and ingestion. Community Dent Oral Epidemiol [Internet].; 1994;22(3):173–80.  

​8. EFSA Scientific Committee, Bennekou SH, Allende A, Bearth A, Casacuberta J, Castle L, et al. Updated consumer risk assessment of fluoride in food and drinking water including the contribution from other sources of oral exposure. EFSA J [Internet]. . 2025;23(7):e9478. 

​9. Skórka-Majewicz M, Goschorska M, Żwierełło W, Baranowska-Bosiacka I, Styburski D, Kapczuk P, et al. Effect of fluoride on endocrine tissues and their secretory functions — review. Chemosphere [Internet]. 2020;260(127565):127565. .  

​10. Proposal to classify sodium fluoride as an endocrine disruptor and reproductive toxicant [Internet]. Anses.fr. [citado el 10 de febrero de 2026]. Disponible en: https://www.anses.fr/en/content/proposal-classify-sodium-fluoride-endocrine-disruptor-and-reproductive-toxicant. 

​11. Annex VI. Proposal for Harmonised Classification and Labelling [Internet]. Europa.eu. [citado el 11 de febrero de 2026]. Disponible en: https://echa.europa.eu/documents/10162/2ff4ec4d-58c7-02c6-39d1-4b11e0c03843.  

​12. Catassi C, Bai JC, Bonaz B, Bouma G, Calabrò A, Carroccio A, et al. Non-Celiac Gluten sensitivity: the new frontier of gluten related disorders. Nutrients [Internet]. 2013;5(10):3839–53.  

​13. Rubio-Tapia A, Hill ID, Kelly CP, Calderwood AH, Murray JA. ACG Clinical Guidelines: Diagnosis and Management of Celiac Disease. The American Journal of Gastroenterology. 2013; 108(5):656–76.  

​14. Farrell RJ, Kelly CP. Celiac Sprue. New England Journal of Medicine. 2002 Jan 17; 346(3):180–8.

​15. Herlofson BB, Barkvoll P. Sodium lauryl sulfate and recurrent aphthous ulcers. A preliminary study. Acta Odontol Scand. 1994 Oct;52(5):257-9.  

​16. Sabri H, Derakhshan Barjoei MM, Azarm A, Sadighnia N, Shakiba R, Aghebati G, Hadilou N, Kheiri P, Ghanbari F, Deravi N, Mokhtari M. The Yin and Yang of Sodium Lauryl Sulfate Use for Oral and Periodontal Health: A Literature Review. J Dent (Shiraz). 2023. Sep;24(3):262-276. 

​17. Darbre PD, Harvey PW. Paraben esters: review of recent studies of endocrine toxicity, absorption, esterase and human exposure, and discussion of potential human health risks. J Appl Toxicol [Internet]. 2008;28(5):561–78. .  

​18. Soni MG, Carabin IG, Burdock GA. Safety assessment of esters of p-hydroxybenzoic acid (parabens). Food and Chemical Toxicology. 2005 Jul; 43(7):985–1015.  

​19. Boberg J, Taxvig C, Christiansen S, Hass U. Possible endocrine disrupting effects of parabens and their metabolites. Reprod Toxicol. 2010 Sep;30(2):301-12.  

​20. Boyer, Ivan & Bergfeld, Wilma & Heldreth, Bart & Fiume, Monice & Gill, Lillian. (2017). The Cosmetic Ingredient Review Program—Expert Safety Assessments of Cosmetic Ingredients in an Open Forum. International Journal of Toxicology. 36. 5S-13S. .  

​21. Weatherly LM, Gosse JA. Triclosan exposure, transformation, and human health effects. Journal of Toxicology and Environmental Health, Part B [Internet]. 2017 Nov 17;20(8):447–69. .  

​22. Dann AB, Hontela A. Triclosan: environmental exposure, toxicity and mechanisms of action. J Appl Toxicol. 2011 May;31(4):285-311. .  

​23. Carey DE, McNamara PJ. The impact of triclosan on the spread of antibiotic resistance in the environment. Frontiers in Microbiology [Internet]. 2015 Jan 15;5. .  

​24. Jones CG. Chlorhexidine: is it still the gold standard? Periodontology 2000. 1997 Oct;15(1):55–62.  

​25. FLÖTRA L, GJERMO P, RÖLLA G, WAERHAUG J. Side effects of chlorhexidine mouth washes. European Journal of Oral Sciences. 1971 Apr;79(2):119–25.  

​26. Van Strydonck DAC, Slot DE, Van der Velden U, Van der Weijden F. Effect of a chlorhexidine mouthrinse on plaque, gingival inflammation and staining in gingivitis patients: a systematic review. Journal of Clinical Periodontology. 2012 Sep 7;39(11):1042–55.  

​27. Gunsolley JC. A meta-analysis of six-month studies of antiplaque and antigingivitis agents. J Am Dent Assoc [Internet]. 2006;137(12):1649–57.  

​28. Addy M. Chlorhexidine compared with other locally delivered antimicrobials. A short review. Journal of Clinical Periodontology. 1986 Nov;13(10):957–64.  

​29. Åke Bergman, Heindel JJ, Jobling S, Kidd KA, R Thomas Zoeller, World Health Organization, et al. State of the science of endocrine disrupting chemicals – 2012 : an assessment of the state of the science of endocrine disruptors prepared by a group of expe.  

​30. Arias M, Castro-Feijóo L, Conde J, Cabanas Rodríguez P. Rev Esp Endocrinol Pediatr 2020 -Volumen 11. REVISIONES Rev Esp Endocrinol Pediatr [Internet]. 2020;11(2). .  

​31. Diamanti-Kandarakis E, Bourguignon JP, Giudice LC, Hauser R, Prins GS, Soto AM, et al. Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement. Endocrine Reviews [Internet]. 2009 Jun;30(4):293–342.  

​32. Vandenberg LN, Colborn T, Hayes TB, Heindel JJ, Jacobs DR, Lee DH, et al. Hormones and Endocrine-Disrupting Chemicals: Low-Dose Effects and Nonmonotonic Dose Responses. Endocrine Reviews [Internet]. 2012 Jun;33(3):378–455.  

​33. Holmer ML, Holmberg RD, Despicht C, Bouftas N, Axelstad M, Beronius A, et al. Assessment of endocrine disruptors in the European Union: Current regulatory framework, use of new approach methodologies (NAMs) and recommendations for improvements. Regul Toxi.  

​34. Lemos CA Jr, Villoria GEM. Reviewed evidence about the safety of the daily use of alcohol-based mouthrinses. Braz Oral Res [Internet]. 2008;22 Suppl 1:24–31.  

​35. McCullough M, Farah C. The role of alcohol in oral carcinogenesis with particular reference to alcohol-containing mouthwashes. Australian Dental Journal. 2008 Dec;53(4):302–5.